Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: JAMA Neurol. 2016 Jun 1;73(6):721–732. doi: 10.1001/jamaneurol.2016.0580

Table.

Demographic Characteristics and Medical Histories of 402 Participants From the ADNI

Characteristic Participants, No. P Value
AC
(n = 350)
AC+
(n = 52)
Age, mean (SD), y 73.3 (5.8) 73.3 (6.6) .96
Sex
    Male 171 18 .06
    Female 179 34
Education, mean (SD), y 16.4 (2.6) 16.1 (2.7) .40
Handedness
    Right 318 50 .20
    Left 32 2
APOE ε4 positive, % of participants 28.0 25.0 .65
Non-Hispanic white, % of participants 84.6 94.2 .06
Medications, mean (SD), Total No. 4.2 (2.8) 6.7 (3.1) <.001
Comorbid conditions, mean (SD), Total No. 1.8 (1.3) 2.2 (1.5) .03
Transient ischemic attack
    No 341 51 .78
    Yes 9 1
Myocardial infarction
    No 325 51 .15
    Yes 25 1
Cardiac surgery
    No 330 50 .58
    Yes 20 2
Hypertension
    No 193 24 .23
    Yes 157 28
Hyperlipidemia
    No 181 29 .59
    Yes 169 23
Diabetes
    No 324 49 .67
    Yes 26 3
Sleep apnea
    No 334 49 .70
    Yes 16 3
Other vascular conditions (eg, atrial fibrillation)
    No 327 47 .42
    Yes 23 5
Anxiety
    No 342 47 .01
    Yes 8 5
Depression
    No 306 37 .002
    Yes 44 15
Insomnia
    No 338 46 .01
    Yes 12 6
ADD or ADHD
    No 348 52 .59
    Yes 2 0
Other psychiatric condition (eg, posttraumatic stress disorder)
    No 348 52 .56
    Yes 2 0
Concussion
    No 331 48 .51
    Yes 19 4

Abbreviations: AC+, participant taking anticholinergic medication with medium or high anticholinergic activity; AC, participant not taking anticholinergic medication; ADD, attention-deficit disorder; ADHD, attention-deficit/ hyperactivity disorder; ADNI, Alzheimer’s Disease Neuroimaging Initiative.